ライフサイエンスコーパス: subclavian

1 ous transluminal angioplasty stenting of the subclavian).

2 [95% CI, 2.11-4.04]; I = 24%), compared with subclavian.

3 The incidence of colonization was subclavian: 0.881 colonization/1,000 catheter days (0.45

4 l.In group 1, the incidence of infection was subclavian: 0.881 infections/1,000 catheter days (0.45%)

5 (95% confidence interval, 1.23-3.04) and for subclavian 1.63 (95% confidence interval, 1.08-2.46).

6 were used through the transfemoral (65.0%), subclavian (3.1%), or transapical (31.9%) approach.

7 Ten studies (3250 subclavian, 3053 internal jugular, and 1554 femoral vein

8 internal jugular) = 50.6%, SD = 23.4%; mean (subclavian) = 48.4%, SD = 26.8%.

9 e either transarterial (transfemoral, 74.6%; subclavian, 5.8%; and other, 1.8%) or transapical (17.8%

10 arterial (transfemoral 73%, transapical 18%, subclavian 6%, and transaortic or transcarotid 3%) or, i

11 of patients and frequent involvement of the subclavian (65%) and carotid (43%) arteries.Ninety-three

12 (internal jugular) = 93.9%, SD = 10.2; mean (subclavian) = 91.5%, SD = 17.1 (p < .0005).

13 Both axillary and subclavian access increased the hazard of failure (P=0.0

14 When subclavian access is not possible, controversy exists be

15 Subclavian access protected from dressing disruption.

16 Subclavian access should be considered a valid option no

17 Image quality of the subclavian and aortoiliofemoral arterial tree and confid

18 also involve large arteries, especially the subclavian and axillary arteries.

19 ne-anesthetized newborn pigs by occlusion of subclavian and brachiocephalic arteries, and changes in

20 considered to be the procedure of choice for subclavian and brachiocephalic obstruction, little work

21 After suboptimal angioplasty, treatment of subclavian and brachiocephalic vein stenoses with a Wall

22 inserted at the femoral site as compared to subclavian and internal jugular placement.

23 is when the femoral site was compared to the subclavian and internal jugular sites combined.

24 er-related bloodstream infection between the subclavian and internal jugular sites.

25 between the long axis and short axis at the subclavian and internal jugular sites.

26 tream infections from femoral as compared to subclavian and internal jugular venous catheterization h

27 Subclavian antiseptic-bonded CVCs combined with standard

28 gistic EuroSCORE (p < 0.001), transapical or subclavian approach (p < 0.001 for both vs. transfemoral

29 The subclavian approach for TAVI is safe and feasible, with

30 ess the procedural and 2-year results of the subclavian approach for transcatheter aortic valve impla

31 Both sites are acceptable when a subclavian approach is not feasible.

32 Subclavian approach was used in 141 patients (61% men; m

33 reValve Registry who underwent TAVI with the subclavian approach were included.

34 The subclavian approach with the CoreValve prosthesis (Medtr

35 Seventy-one of 91 left subclavian arterial segments had loss of signal intensit

36 aortic arch between the innominate and left subclavian arteries are not accounted for adequately in

37 anese macaques exhibited only innominate and subclavian arteries arising from the aortic arch, macros

38 We show that there are supernumerary subclavian arteries in talpid(3) limb buds and abnormal

39 10-15-minute clipping of both innominate and subclavian arteries.

40 t radial artery while there were bruits over subclavian arteries.

41 aortic coarctation (12%), and aberrant right subclavian artery (8%).

42 = 22); right aortic arch with aberrant left subclavian artery (n = 28); right aortic arch with mirro

43 4); and left aortic arch with aberrant right subclavian artery (n = 7).

44 or right aortic arch (seven cases), aberrant subclavian artery (six cases), innominate artery compres

45 n palliated with a shunt usually between the subclavian artery and either pulmonary artery.

46 ts such as interrupted aortic arch, aberrant subclavian artery and Tetralogy of Fallot, demonstrating

47 orta and shortened distance between the left subclavian artery and the site of injury.

48 Axillary subclavian artery aneurysm or occlusion was treated succ

49 arch artery that results in aortic arch and subclavian artery anomalies in 95% of mutants; these def

50 30 patients (7.4%) developed carotid and/or subclavian artery disease at a median of 17 years after

51 elated factor was associated with carotid or subclavian artery disease or valvular dysfunction.

52 Aberrant R/subclavian artery is a rare congenital anomaly involving

53 MR) angiography, artifactual stenosis of the subclavian artery is sometimes seen adjacent to the subc

54 phageal carcinoma with associated aberrant R/subclavian artery is very rare and only few cases has be

55 sal,attributable to occlusive disease in the subclavian artery proximal to that branch that is usuall

56 to arterial insufficiency in a branch of the subclavian artery stemming from flow reversal,attributab

57 he objective was to assess the prevalence of subclavian artery stenosis (SS) in four cohorts (two fre

58 Subclavian artery stenosis was defined as > or =15 mm Hg

59 pulse wave transit time from the root of the subclavian artery to aortic bifurcation (T(Ao)) was meas

60 ulated and perfused with blood from the left subclavian artery under systemic blood pressure through

61 m abduction (n = 9), more than 50% change in subclavian artery velocity in abduction by duplex scan (

62 Transposition of the left subclavian artery was necessary to relieve left arm isch

63 th type II endoleak formation (from the left subclavian artery), two with type IIo endoleak formation

64 rrupted aortic artery, retroesophageal right subclavian artery, and ventricular septum defect, which

65 in the aortic arch, carotid sinus, and right subclavian artery, as well as in the carotid body.

66 of an injury with extension proximal to the subclavian artery, involvement of branch vessels, or req

67 h the left atrium (LA) and an aberrant right subclavian artery, misdiagnosed as primary mitral regurg

68 ng aorta, one ruptured aneurysm of the right subclavian artery, one case of myocarditis, and one pulm

69 right aortic arch, and retroesophageal right subclavian artery.

70 oximal branch vessels, particularly the left subclavian artery.

71 placed with its tip just distal to the left subclavian artery.

72 oma with incidentally co-existing aberrant R/subclavian artery.

73 iocephalic artery, and retroesophageal right subclavian artery.

74 Seventy-four case patients with subclavian/axillary GCA diagnosed by angiography and 74

75 cal artery stenosis, and 6 (4%) had incident subclavian/axillary/brachial artery stenosis.

76 of 6 different human macrovessels (aorta and subclavian, carotid, mesenteric, iliac, and temporal art

77 ts, only 7 underwent an intervention (2 with subclavian-carotid bypass and 5 with percutaneous transl

78 Subclavian catheter and lead malfunction is not due to c

79 Subclavian catheter placement had the longest dwell time

80 was not significant when the data from five subclavian catheter trials were pooled (relative risk of

81 ltrasound compared to landmark technique for subclavian catheterization in adult populations were con

82 Ultrasound-guided subclavian catheterization reduced the frequency of adve

83 support the use of dynamic 2D ultrasound for subclavian catheterization to reduce adverse events and

84 Subclavian catheters were in place longer than femoral o

85 quartile range, 9-40), and ultrasound-guided subclavian catheters were three (interquartile range, 0-

86 All patients in whom subclavian central line insertion is planned should have

87 et or exceeded the minimum passing score for subclavian central venous catheter insertion.

88 residents met the minimum passing score for subclavian central venous catheter insertion: mean (inte

89 0.4% and 2.3% pneumothorax with jugular and subclavian central venous catheter insertions, respectiv

90 ation-based training in internal jugular and subclavian central venous catheter insertions.

91 Using the long-axis view for subclavian central venous catheterization and avoiding p

92 The long-axis approach to subclavian central venous catheterization is also associ

93 The long-axis view for subclavian central venous catheterization was also more

94 Subclavian could be suggested as the most appropriate si

95 All hemophilia patients with tunneled subclavian CVCs in place for 12 months or more were cand

96 develop bacterial colonization earlier than subclavian CVCs.

97 ting (n = 49), bypass grafting (n = 30), and subclavian flap or "other" (n = 35).

98 =0.003) and in the jugular group than in the subclavian group (hazard ratio, 2.1; 95% CI, 1.0 to 4.3;

99 ntly higher in the femoral group than in the subclavian group (hazard ratio, 3.5; 95% confidence inte

100 Survival at 2 years was 74.0 +/- 4.0% in the subclavian group compared with 73.7 +/- 3.9% in the femo

101 The subclavian group showed lower rates of acute kidney inju

102 in the subclavian vein (internal jugular vs. subclavian: hazard ratio 3.29; 95% confidence interval 1

103 nce interval 1.26-8.61; p = .01; femoral vs. subclavian: hazard ratio 3.36; 95% confidence interval 1

104 risk was comparable for internal jugular and subclavian, higher for femoral than subclavian (relative

105 once with the proximal electrode in the left subclavian-innominate vein (innominate vein position).

106 the proximal defibrillation electrode in the subclavian-innominate vein will lower defibrillation ene

107 Both A (radial/brachial) and B (axillary/subclavian/innominate) variants exhibited concordance ac

108 ese data support the preferential use of the subclavian insertion site and enhanced efforts to reduce

109 The subclavian, internal jugular, and femoral sites were stu

110 s catheter infection and colonization at the subclavian, internal jugular, and femoral sites.

111 d colonization risk between the three sites (subclavian, internal jugular, and femoral) in adult ICU

112 y inserted, noncuffed CVCs inserted into the subclavian, internal jugular, or femoral vein in two ran

113 oodstream infections between the femoral and subclavian/internal jugular sites in the two randomized

114 exist on alternative site selection whenever subclavian is contraindicated.

115 8, 20, and 22 primary outcome events in the subclavian, jugular, and femoral groups, respectively (1

116 n the adult intensive care unit (ICU) to the subclavian, jugular, or femoral vein (in a 1:1:1 ratio i

117 l penetration were significantly less in the subclavian long axis (odds ratio, 0.3; 95% CI, 0.1-0.9).

118 ong axis 21%, subclavian short axis 64%, and subclavian long axis 39%.

119 In ICU patients, internal jugular and subclavian may, similarly, decrease catheter-related blo

120 rrect; interquartile range, 22.22-68.97) and subclavian (median, 33.33%; interquartile range, 0.00-70

121 rrect; interquartile range, 68.97-86.21) and subclavian (median, 83.00%; interquartile range, 59.00-8

122 ian, 96%; interquartile range, 93.10-100.00; subclavian: median, 100%; interquartile range, 96.00-100

123 nts who underwent Wallstent insertion into a subclavian (n = 11) or brachiocephalic (n = 9) vein were

124 Vascular access was transfemoral (n = 35), subclavian (n = 4), direct aortic (n = 3), and carotid (

125 bjected to 5 minutes of aortic arch and left subclavian occlusion with subsequent reperfusion to gene

126 idance to cannulate the internal jugular and subclavian of a human torso mannequin using the long-axi

127 Women, patients with leads inserted via the subclavian or axillary vein, and those with a previous l

128 giant-cell arteritis with occlusions in the subclavian or axillary vessels; aortic giant-cell arteri

129 Subclavian or brachiocephalic artery obstruction can be

130 ould be considered as first line therapy for subclavian or brachiocephalic obstruction.

131 group, the coronary sinus was cannulated via subclavian or femoral venous approaches, and aspiration

132 Patients receiving ultrasound-guided subclavian or internal jugular central venous catheters.

133 rs placed in the femoral site as compared to subclavian or internal jugular placement.

134 To test that hypothesis, subclavian-pulmonary artery anastomoses were created in

135 y vascular remodeling was not induced by the subclavian-pulmonary artery anastomosis alone.

136 ther than injury plus increased flow, a left subclavian-pulmonary artery anastomosis was substituted

137 ents included instantaneous aortic pressure (subclavian pulse tracings) and flow (aortic Doppler velo

138 ular and subclavian, higher for femoral than subclavian (relative risk, 2.44 [95% CI, 1.25-4.75]; I =

139 Subclavian revascularizations were performed selectively

140 rior vena cava (SVC), brachiocephalic (BCV), subclavian (SCV) and internal jugular vein (IJV).

141 rt axis 25%, internal jugular long axis 21%, subclavian short axis 64%, and subclavian long axis 39%.

142 er site complication is warranted before the subclavian site can be unequivocally recommended as a fi

143 Our analysis suggests that the subclavian site may be associated with a lower risk of c

144 The subclavian site was used in 41 patients (64%) (inserted

145 of redirections at the internal jugular and subclavian sites, relative risk 0.4 (95% CI, 0.2-0.9) an

146 oodstream infections between the femoral and subclavian sites.

147 nosis (so called"coronary-subclavian steal").Subclavian steal may also manifest as vertebrobasilar in

148 fficiency or,most commonly, arm claudication.Subclavian steal should be considered among patients exh

149 ciated with retrograde flow in patients with subclavian steal syndrome, compared with patients with n

150 n the appropriate clinical setting, indicate subclavian steal syndrome.

151 ean, 2.5 seconds) in all eight patients with subclavian steal syndrome.

152 "Subclavian steal" refers to a syndrome of symptoms relat

153 o the graft and stenosis (so called"coronary-subclavian steal").Subclavian steal may also manifest as

154 was 36.9 mm Hg (95% CI 35.4-38.4) for proven subclavian stenosis (>50% occlusion), and a difference o

155 0 mm Hg or more was strongly associated with subclavian stenosis (risk ratio [RR] 8.8, 95% CI 3.6-21.

156 This study sought to assess the prognosis of subclavian stenosis (SS) as a potential marker of total

157 women aged 54-80 years; mean, 70 years) had subclavian stenosis or occlusion with retrograde vertebr

158 Subclavian stenosis was found in 157 (8.8%) subjects.

159 Subclavian stenosis, diagnosed by a brachial systolic pr

160 fferences in SBP between arms, with data for subclavian stenosis, peripheral vascular disease, cerebr

161 Subclavian stenosis,regardless of symptoms, is a marker

162 onal angiography can confirm the presence of subclavian stenosis.

163 eripheral vascular disease and attributed to subclavian stenosis.

164 The subclavian thrombosis was discovered accidentally from t

165 culation over the chest wall consistent with subclavian thrombosis.

166 onic aortoiliac occlusive disease undergoing subclavian transcatheter aortic valve implantation to av

167 n the transvenous lead configurations with a subclavian vein (29.0+/-2.5 J, P=.0001) or a superior ve

168 be colonized than catheters inserted in the subclavian vein (internal jugular vs. subclavian: hazard

169 ned in the right atrial appendage (RA), left subclavian vein (LSV), proximal coronary sinus (CSos), a

170 from the internal jugular vein (IJV) or the subclavian vein (SCV) can result in rare but significant

171 Subclavian vein access was used for a superior approach

172 ressure to transport lymph downstream to the subclavian vein against a significant pressure head.

173 n criteria, one of which was randomized (136 subclavian vein and 134 femoral vein).

174 rated venous obstruction at the level of the subclavian vein and abnormal collateral circulation over

175 placed via Seldinger technique into the left subclavian vein and superior vena cava and evaluated for

176 h extended helix was introduced via the left subclavian vein and, after positioning against the right

177 led central venous catheters inserted in the subclavian vein are associated with lower risk of cathet

178 Although ultrasound guidance for subclavian vein catheterization has been well described,

179 to determine whether ultrasound guidance of subclavian vein catheterization reduces catheterization

180 ertion failure and complication rates during subclavian vein catheterization.

181 Subclavian vein catheters were left in place significant

182 Due to Tortuosity and lack of stamp of right subclavian vein contributed to the decision to perform r

183 ght internal jugular vein in 4, and the left subclavian vein in 2 patients.

184 t can placement was investigated by adding a subclavian vein lead to the pectoral or abdominal hot ca

185 .9+/-3.2 J) for the abdominal hot can with a subclavian vein lead was lower than the transvenous lead

186 The addition of a subclavian vein lead with an abdominal hot can improves

187 The addition of a right or left subclavian vein lead with an abdominal hot can reduced t

188 The overall subclavian vein occlusion rate was 10 of 13 (77%) <5 kg

189 Subclavian vein occlusion remains an important complicat

190 ian artery is sometimes seen adjacent to the subclavian vein on the side of the contrast material inj

191 Subclavian vein patency was assessed in 26 patients.

192 ght ventricular apex/outflow tract through a subclavian vein puncture with a redundant loop in the at

193 The subclavian vein site was associated with fewer catheter-

194 Subclavian vein thrombosis (SVT) is usually caused by vi

195 A 79-yr-old woman with asymptomatic subclavian vein thrombosis associated with transvenous p

196 ad dislodgment in 4 requiring correction and subclavian vein thrombosis in 1 patient.

197 One patient developed subclavian vein thrombosis, and no patients developed ne

198 One patient developed subclavian vein thrombosis.

199 ; 95% confidence interval [0.30-0.70], I=0%; subclavian vein vs. femoral vein, incidence density rati

200 risons were stratified by alternative sites (subclavian vein vs. internal jugular vein, incidence den

201 hundred thirty catheters were placed in the subclavian vein, 10,958 in the internal jugular and 3,18

202 dilation or cannulation) was 1.3% using the subclavian vein.

203 In this trial, subclavian-vein catheterization was associated with a lo

204 ccurred in association with 13 (1.5%) of the subclavian-vein insertions and 4 (0.5%) of the jugular-v

205 ing vein drained the right jugular and right subclavian veins and joined the left brachiocephalic vei

206 heters of the internal jugular, brachial, or subclavian veins were eligible for participation.

207 lls (ECs) at the junction of the jugular and subclavian veins.

208 sels only at the junction of the jugular and subclavian veins.

209 adiography was performed on 10 patients with subclavian venous catheter dysfunction and three patient

210 cations associated with internal jugular and subclavian venous catheter placement.

211 as 87.2 +/- 3.1% versus 88.7 +/- 2.8% in the subclavian versus femoral group, respectively (p = 0.84)

212 by differential responsiveness of iliac and subclavian vessels to TLR5 but not TLR4 ligands.

213 The long-axis view for subclavian was associated with decreased time to cannula

214 Although subclavian was considered the most appropriate site, its

215 laced was 27 (interquartile range, 9-42) and subclavian was six catheters (interquartile range, 2-20)